LDP

L-DOPAMINE

Created: 1999-07-08
Last modified:  2020-06-05

Find related ligands:

Chemical Details

Formal Charge0
Atom Count22
Chiral Atom Count0
Bond Count22
Aromatic Bond Count6
2D diagram of LDP

Chemical Component Summary

NameL-DOPAMINE
SynonymsDOPAMINE
Systematic Name (OpenEye OEToolkits)4-(2-aminoethyl)benzene-1,2-diol
FormulaC8 H11 N O2
Molecular Weight153.178
TypeNON-POLYMER

Chemical Descriptors

TypeProgram Version Descriptor
SMILESACDLabs10.04Oc1ccc(cc1O)CCN
SMILESCACTVS3.341NCCc1ccc(O)c(O)c1
SMILESOpenEye OEToolkits1.5.0c1cc(c(cc1CCN)O)O
Canonical SMILESCACTVS3.341 NCCc1ccc(O)c(O)c1
Canonical SMILESOpenEye OEToolkits1.5.0 c1cc(c(cc1CCN)O)O
InChIInChI1.03 InChI=1S/C8H11NO2/c9-4-3-6-1-2-7(10)8(11)5-6/h1-2,5,10-11H,3-4,9H2
InChIKeyInChI1.03 VYFYYTLLBUKUHU-UHFFFAOYSA-N

Drug Info: DrugBank

DrugBank IDDB00988 
NameDopamine
Groups approved
DescriptionOne of the catecholamine neurotransmitters in the brain. It is derived from tyrosine and is the precursor to norepinephrine and epinephrine. Dopamine is a major transmitter in the extrapyramidal system of the brain, and important in regulating movement. A family of receptors (receptors, dopamine) mediate its action.
Synonyms
  • Dopaminum
  • Dopamine
  • 3,4-Dihydroxyphenethylamine
  • 4-(2-aminoethyl)catechol
  • Dopamine hydrochloride
Brand Names
  • Dopamine HCl 0.8mg/ml Dextrose 5% Inj USP
  • Dopamine Hci
  • DOPamine Hydrochloride
  • Intropin Injection 40mg/ml
  • Dopamine Hydrochloride and 5% Dextrose Injection USP
IndicationFor the correction of hemodynamic imbalances present in the shock syndrome due to myocardial infarction, trauma, endotoxic septicemia, open-heart surgery, renal failure, and chronic cardiac decompensation as in congestive failure
Categories
  • Adrenergic and Dopaminergic Agents
  • Agents producing tachycardia
  • Agents that produce hypertension
  • Amines
  • Autonomic Agents
ATC-CodeC01CA04
CAS number51-61-6

Drug Targets

NameTarget SequencePharmacological ActionActions
Dopamine D2 receptorMDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVF...unknownagonist
Dopamine D1 receptorMRTLNTSAMDGTGLVVERDFSVRILTACFLSLLILSTLLGNTLVCAAVIR...unknownagonist
Dopamine D5 receptorMLPPGSNGTAYPGQFALYQQLAQGNAVGGSAGAPPLGPSQVVTACLLTLL...unknownagonist
Dopamine D3 receptorMASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLV...unknownagonist
Dopamine D4 receptorMGNRSTADADGLLAGRGPAAGASAGASAGLAGQGAAALVGGVLLIGAVLA...unknownagonist
View More
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682

Related Resource References

Resource NameReference
Pharos CHEMBL59
PubChem 681
ChEMBL CHEMBL59
ChEBI CHEBI:18243
CCDC/CSD DOPAMN02, DOPAMN